Referred TestsHead and neck pathology
All in one place.
Head and neck pathology consultations often relate to the classification of salivary, sinonasal, and oropharynx tumors. Our experts contribute heavily to the clinical practice and are also involved in education, research, and test development.
4,000+
cases seen each year
4
sub-specialtized patholgists
Pathology in Focus
David Schembri-Wismayer, M.D. gives an overview of the head and neck pathology service and the benefits of testing through Mayo Clinic Laboratories.
Expertise
Joaquin Garcia, M.D.
Medical School
Stanford University School of Medicine
Residency
University of California San Francisco
Fellowship
Surgical Pathology
Oncologic Surgical Pathology
Molecular Pathology
Head & Neck Pathology
University of Pittsburgh Medical Center
Memorial Sloan-Kettering Cancer Center
University of California San Francisco
Jean Lewis, M.D.
Medical School
Mayo Clinic College of Medicine
Residency
Mayo Clinic College of Medicine
Fellowship
Surgical Pathology
Mayo Clinic College of Medicine
Michael Rivera, M.D.
Medical School
SUNY Downstate Medical Center College of Medicine
Residency
New York Presbyterian Hospital
Fellowship
Surgical Pathology
Cytopathology
Head and Neck Pathology
Memorial Sloan-Kettering Cancer Center
David Schembri-Wismayer, M.D
Section Head
Medical School
University of Malta School of Medicine
Residency
St. Luke's Teaching Hospital
Mayo Clinic College of Medicine
Fellowship
Surgical Pathology
Mayo Clinic College of Medicine
Testing
PATHC | Pathology Consultation
Salivary Gland
ETVBF | ETV6 (12p13.2) Rearrangement, FISH
Providing diagnostic and prognostic information for patients with various lymphoid and myeloid malignancies
ETV6F | ETV6 (12p13.2) Rearrangement, FISH, Tissue
Rearrangement supports the diagnosis of secretory carcinoma
EWSF | Ewing Sarcoma (EWS), 22q12 (EWSR1) Rearrangement, FISH, Tissue
Rearrangement supports the diagnosis of clear cell carcinoma
MAMLF | MAML2 (11q21) Rearrangement, Mucoepidermoid Carcinoma (MEC), FISH, Tissue
Rearrangement supports the diagnosis of mucoepidermoid carcinoma
SGTF | MYB (6q23) Rearrangement FISH, Tissue
Rearrangement supports the diagnosis of adenoid cystic carcinoma
Sinonasal
NUT | NUT Immunostain, Technical Component Only
Expression supports the diagnosis of NUT carcinoma
NUTIF | NUTM1 (15q14) Rearrangement, FISH, Tissue
Rearrangement supports the diagnosis of NUT carcinoma
P16 | p16 (INK4a/CDKN2A) Immunostain, Technical Component Only
Overexpression supports the presence of high-risk HPV genotypes
HPVHR | Human Papillomavirus (HPV), High-Risk, DNA In Situ Hybridization
Hybridization supports the presence of high-risk HPV genotypes
HPVE6 | Human Papillomavirus (HPV) High-Risk E6/E7, RNA In Situ Hybridization
Stratification of oropharyngeal squamous cell carcinoma
Oropharynx
P16 | p16 (INK4a/CDKN2A) Immunostain, Technical Component Only
Overexpression supports the presence of high-risk HPV genotypes
HPVHR | Human Papillomavirus (HPV), High-Risk, DNA In Situ Hybridization
Hybridization supports the presence of high-risk HPV genotypes
HPVE6 | Human Papillomavirus (HPV) High-Risk E6/E7, RNA In Situ Hybridization
Stratification of oropharyngeal squamous cell carcinoma
Larynx
HPVHR | Human Papillomavirus (HPV), High-Risk, DNA In Situ Hybridization
Hybridization supports the presence of high-risk HPV genotypes
HPVE6 | Human Papillomavirus (HPV) High-Risk E6/E7, RNA In Situ Hybridization
Stratification of oropharyngeal squamous cell carcinoma
HPVLR | Human Papillomavirus (HPV) Low Risk, DNA In Situ Hybridization
Detection of human papillomavirus (HPV) DNA from low-risk genotypes (6, 11)
Learn more about how to order these evaluations at your institution.